Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29267

1.

Hospital Medicine Update: High-Impact Literature from March 2018 to April 2019.

Donovan AK, Burger A, Moriates C, Sharpe BA, Herzke C.

J Hosp Med. 2019 Oct 23;14:E1-E5. doi: 10.12788/jhm.3321. [Epub ahead of print] Review.

PMID:
31634096
2.

PREVENTABLE ADVERSE DRUG EVENTS: DESCRIPTIVE EPIDEMIOLOGY.

Woo SA, Cragg A, Wickham ME, Villanyi D, Scheuermeyer F, Hau JP, Hohl CM.

Br J Clin Pharmacol. 2019 Oct 21. doi: 10.1111/bcp.14139. [Epub ahead of print]

PMID:
31633827
3.

Direct Oral Anticoagulant Use Following Transcatheter Aortic Valve Replacement: A Case Series.

Hendricks AK, Nei SD, Greason KL, Scott RA.

J Cardiovasc Pharmacol. 2019 Sep 30. doi: 10.1097/FJC.0000000000000755. [Epub ahead of print]

PMID:
31633585
4.

CYP2C9-mediated warfarin and milk thistle interaction.

Lash DB, Ward S.

J Clin Pharm Ther. 2019 Oct 21. doi: 10.1111/jcpt.13064. [Epub ahead of print]

PMID:
31633199
5.

Combined Central Retinal Vein And Artery Occlusion In A Patient With Elevated Level Of Factor VIII: A Case Report.

Chang IB, Lee JH, Kim HW.

Int Med Case Rep J. 2019 Oct 7;12:309-312. doi: 10.2147/IMCRJ.S217742. eCollection 2019.

PMID:
31632158
6.

Using non-vitamin K oral anticoagulants in specific patient populations: a study of Korean cases.

Cho IY.

Ther Clin Risk Manag. 2019 Oct 8;15:1183-1206. doi: 10.2147/TCRM.S204377. eCollection 2019.

PMID:
31632045
7.

Instruments for the assessment of patient adherence to oral anticoagulation with warfarin protocol for a systematic review.

da Silva Praxedes MF, Sousa Vianna M, Freitas Nunes de Sousa WJ, Bartolazzi F, de Araújo VE, Parreiras Martins MA.

Medicine (Baltimore). 2019 Oct;98(42):e17323. doi: 10.1097/MD.0000000000017323.

8.

Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant.

Kumano O, Moore GW.

Res Pract Thromb Haemost. 2019 Jul 30;3(4):695-703. doi: 10.1002/rth2.12245. eCollection 2019 Oct.

9.

Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study.

Wanat MA, Wang X, Paranjpe R, Chen H, Johnson ML, Fleming ML, Abughosh SM.

Res Pract Thromb Haemost. 2019 Jun 17;3(4):674-683. doi: 10.1002/rth2.12221. eCollection 2019 Oct.

10.

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017.

Lutsey PL, Walker RF, MacLehose RF, Alonso A, Adam TJ, Zakai NA.

Res Pract Thromb Haemost. 2019 Jun 9;3(4):668-673. doi: 10.1002/rth2.12222. eCollection 2019 Oct.

11.

How minimally interrupted direct oral anticoagulants affect intraprocedural anticoagulation during atrial fibrillation ablation? Insights from a Japanese single-center retrospective study.

Mizobuchi M, Funatsu A, Kobayashi T, Nakamura S.

J Arrhythm. 2019 Aug 16;35(5):716-724. doi: 10.1002/joa3.12228. eCollection 2019 Oct.

12.

Use of simplified HAS-BLED score in patients with atrial fibrillation receiving warfarin.

Methavigul K, Methavigul R.

J Arrhythm. 2019 Aug 22;35(5):711-715. doi: 10.1002/joa3.12225. eCollection 2019 Oct.

13.

One-year clinical outcomes of anticoagulation therapy among Japanese patients with atrial fibrillation: The Hyogo AF Network (HAF-NET) Registry.

Hyogo K, Yoshida A, Takeuchi M, Kiuchi K, Fukuzawa K, Takami M, Kobori A, Okajima K, Odake M, Okada T, Shimane A, Kawahara Y, Sekiya J, Sano H, Ichikawa Y, Hirata KI; HAF‐NET Registry Investigators.

J Arrhythm. 2019 Aug 16;35(5):697-708. doi: 10.1002/joa3.12226. eCollection 2019 Oct.

14.

Rapid serum tube technology overcomes problems associated with use of anticoagulants.

Zhao KN, Dimeski G, de Jersey J, Johnson LA, Grant M, Masci PP, Lavin MF.

Biochem Med (Zagreb). 2019 Oct 15;29(3):030706. doi: 10.11613/BM.2019.030706.

15.

Efficacy of Feracrylum as Topical Hemostatic Agent in Therapeutically Anticoagulated Patients Undergoing Dental Extraction: A Comparative Study.

Rai S, Rattan V.

J Maxillofac Oral Surg. 2019 Dec;18(4):579-583. doi: 10.1007/s12663-018-1156-6. Epub 2018 Sep 27.

PMID:
31624440
16.

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients With Atrial Fibrillation.

Chan YH, Lee HF, Wang CL, Chang SH, Yeh CH, Chao TF, Yeh YH, Chen SA, Kuo CT.

J Am Heart Assoc. 2019 Nov 5;8(21):e013053. doi: 10.1161/JAHA.119.013053. Epub 2019 Oct 18.

17.

Osteocalcin and its forms across the lifespan in adult men.

Smith C, Voisin S, Al Saedi A, Phu S, Brennan-Speranza T, Parker L, Eynon N, Hiam D, Yan X, Scott D, Blekkenhorst LC, Lewis JR, Seeman E, Byrnes E, Flicker L, Duque G, Yeap BB, Levinger I.

Bone. 2019 Oct 14:115085. doi: 10.1016/j.bone.2019.115085. [Epub ahead of print]

PMID:
31622778
18.

Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies.

Bauersachs R, Langer F, Kalka C, Konstantinides S, Klamroth R, Oldenburg J, Schellong S, Scholz U, Stücker M, Lindhoff-Last E.

Vasa. 2019 Nov;48(6):483-486. doi: 10.1024/0301-1526/a000815. Epub 2019 Aug 20.

PMID:
31621546
19.

Intramural Hematoma Causing Hematochezia After Colonoscopy With Polypectomy.

Gavrić A, Dežman R, Stefanović S, Drnovšek J, Štabuc B.

ACG Case Rep J. 2019 Jul 11;6(7):e00129. doi: 10.14309/crj.0000000000000129. eCollection 2019 Jul.

20.

Protocol for AREST: Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation-A Randomized Controlled Trial of Early Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation.

Rose DZ, Meriwether JN, Fradley MG, Renati S, Martin RC, Kasprowicz T, Patel A, Mokin M, Murtagh R, Kip K, Bozeman AC, McTigue T, Hilker N, Kirby B, Wick N, Tran N, Burgin WS, Labovitz AJ.

Front Neurol. 2019 Sep 20;10:975. doi: 10.3389/fneur.2019.00975. eCollection 2019.

Supplemental Content

Loading ...
Support Center